An RNA interference phenotypic screen identifies a role for FGF signals in colon cancer progression

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Leushacke, Marc ^a,b   Spörle, Ralf ^a   Bernemann, Christof ^a   Brouwer Lehmitz, Antje ^a   Fritzmann, Johannes ^c,d   Theis, Mirko ^e,f   Buchholz, Frank ^e,f   Herrmann, Bernhard G ^a,g   Morkel, Markus ^a  

^a MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^d UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^e MAX PLANCK INSTITUTE OF MOLECULAR CELL BIOLOGY AND GENETICS   (Germany)

^f UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^g CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; STRESS ACTIVATED PROTEIN KINASE;

ARTICLE; CANCER CELL; CANCER GROWTH; CELL ADHESION; CELL MOTILITY; CELL STRUCTURE; COLON CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME INHIBITION; EPITHELIUM CELL; FGF9 GENE; GENE; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; PHENOTYPE; PROTEIN FUNCTION; RNA INTERFERENCE; SCREENING TEST; ANIMAL; CELL MOTION; COLON TUMOR; DISEASE COURSE; EPITHELIUM; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC SCREENING; GENETICS; MESODERM; METABOLISM; MOUSE; PATHOLOGY; SIGNAL TRANSDUCTION; SURVIVAL; TUMOR CELL LINE; TUMOR GENE;

ANIMALS; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; COLONIC NEOPLASMS; DISEASE PROGRESSION; EPITHELIUM; FIBROBLAST GROWTH FACTORS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; GENETIC TESTING; HUMANS; MAP KINASE SIGNALING SYSTEM; MESODERM; MICE; PHENOTYPE; RHO GTP-BINDING PROTEINS; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SURVIVAL ANALYSIS;

EID: 80051603744     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0023381     Document Type: Article

References (56)

1. Thiery JP, (2003) Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 15: 740-746.
2. Huber MA, Kraut N, Beug H, (2005) Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol 17: 548-558.
3. Brabletz T, Hlubek F, Spaderna S, Schmalhofer O, Hiendlmeyer E, et al. (2005) Invasion and metastasis in colorectal cancer: epithelial-mesenchymal transition, mesenchymal-epithelial transition, stem cells and beta-catenin. Cells Tissues Organs (Print) 179: 56-65.
4. Thiery JP, Sleeman JP, (2006) Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 7: 131-142.
5. Kalluri R, Weinberg RA, (2009) The basics of epithelial-mesenchymal transition. J Clin Invest 119: 1420-1428.
6. Boyer B, Tucker GC, Valles AM, Franke WW, Thiery JP, (1989) Rearrangements of desmosomal and cytoskeletal proteins during the transition from epithelial to fibroblastoid organization in cultured rat bladder carcinoma cells. J Cell Biol 109: 1495-1509.
7. Sommers CL, Thompson EW, Torri JA, Kemler R, Gelmann EP, et al. (1991) Cell adhesion molecule uvomorulin expression in human breast cancer cell lines: relationship to morphology and invasive capacities. Cell Growth Differ 2: 365-372.
8. Frixen UH, Behrens J, Sachs M, Eberle G, Voss B, et al. (1991) E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 113: 173-185.
9. Batlle E, Sancho E, Franci C, Dominguez D, Monfar M, et al. (2000) The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2: 84-89.
10. Cano A, Perez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, et al. (2000) The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2: 76-83.
11. Price LS, Collard JG, (2001) Regulation of the cytoskeleton by Rho-family GTPases: implications for tumour cell invasion. Semin Cancer Biol 11: 167-173.
12. Huelsken J, Vogel R, Brinkmann V, Erdmann B, Birchmeier C, et al. (2000) Requirement for beta-catenin in anterior-posterior axis formation in mice. J Cell Biol 148: 567-578.
13. Brabletz T, Jung A, Hermann K, Gunther K, Hohenberger W, et al. (1998) Nuclear overexpression of the oncoprotein beta-catenin in colorectal cancer is localized predominantly at the invasion front. Pathol Res Pract 194: 701-704.
14. Brabletz T, Jung A, Dag S, Hlubek F, Kirchner T, (1999) beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am J Pathol 155: 1033-1038.
15. Vermeulen L, De Sousa EMF, van der Heijden M, Cameron K, de Jong JH, et al. (2010) Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat Cell Biol 12: 468-476.
16. Bladt F, Riethmacher D, Isenmann S, Aguzzi A, Birchmeier C, (1995) Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud. Nature 376: 768-771.
17. Threadgill DW, Dlugosz AA, Hansen LA, Tennenbaum T, Lichti U, et al. (1995) Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. Science 269: 230-234.
18. Miettinen PJ, Berger JE, Meneses J, Phung Y, Pedersen RA, et al. (1995) Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor. Nature 376: 337-341.
19. Meyers EN, Lewandoski M, Martin GR, (1998) An Fgf8 mutant allelic series generated by Cre- and Flp-mediated recombination. Nat Genet 18: 136-141.
20. Ciruna B, Rossant J, (2001) FGF signaling regulates mesoderm cell fate specification and morphogenetic movement at the primitive streak. Dev Cell 1: 37-49.
21. Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF, (2003) Met, metastasis, motility and more. Nat Rev Mol Cell Biol 4: 915-925.
22. Hynes NE, Lane HA, (2005) ERBB receptors and cancer: the complexity of targeted inhibitors. Nat Rev Cancer 5: 341-354.
23. Winder T, Lenz HJ, Vascular endothelial growth factor and epidermal growth factor signaling pathways as therapeutic targets for colorectal cancer. Gastroenterology 138: 2163-2176.
24. McKay MM, Morrison DK, (2007) Integrating signals from RTKs to ERK/MAPK. Oncogene 26: 3113-3121.
25. Walther A, Johnstone E, Swanton C, Midgley R, Tomlinson I, et al. (2009) Genetic prognostic and predictive markers in colorectal cancer. Nat Rev Cancer 9: 489-499.
26. Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, et al. (2004) Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117: 927-939.
27. Buchholz F, Kittler R, Slabicki M, Theis M, (2006) Enzymatically prepared RNAi libraries. Nat Methods 3: 696-700.
28. Brembeck FH, Schwarz-Romond T, Bakkers J, Wilhelm S, Hammerschmidt M, et al. (2004) Essential role of BCL9-2 in the switch between beta-catenin's adhesive and transcriptional functions. Genes Dev 18: 2225-2230.
29. Huelsken J, Birchmeier W, (2001) New aspects of Wnt signaling pathways in higher vertebrates. Curr Opin Genet Dev 11: 547-553.
30. Yang L, Xie G, Fan Q, Xie J, (2009) Activation of the hedgehog-signaling pathway in human cancer and the clinical implications. Oncogene 29: 469-481.
31. Bisson N, Poitras L, Mikryukov A, Tremblay M, Moss T, (2007) EphA4 signaling regulates blastomere adhesion in the Xenopus embryo by recruiting Pak1 to suppress Cdc42 function. Mol Biol Cell 18: 1030-1043.
32. Poliakov A, Cotrina M, Wilkinson DG, (2004) Diverse roles of eph receptors and ephrins in the regulation of cell migration and tissue assembly. Dev Cell 7: 465-480.
33. Reynaud C, Fabre S, Jalinot P, (2000) The PDZ protein TIP-1 interacts with the Rho effector rhotekin and is involved in Rho signaling to the serum response element. J Biol Chem 275: 33962-33968.
34. Micalizzi DS, Christensen KL, Jedlicka P, Coletta RD, Baron AE, et al. (2009) The Six1 homeoprotein induces human mammary carcinoma cells to undergo epithelial-mesenchymal transition and metastasis in mice through increasing TGF-beta signaling. J Clin Invest 119: 2678-2690.
35. Christensen KL, Patrick AN, McCoy EL, Ford HL, (2008) The six family of homeobox genes in development and cancer. Adv Cancer Res 101: 93-126.
36. Mohammadi M, McMahon G, Sun L, Tang C, Hirth P, et al. (1997) Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors. Science 276: 955-960.
37. Hall A, (2009) The cytoskeleton and cancer. Cancer Metastasis Rev 28: 5-14.
38. Turner N, Grose R, (2010) Fibroblast growth factor signalling: from development to cancer. Nat Rev Cancer 10: 116-129.
39. Vial E, Sahai E, Marshall CJ, (2003) ERK-MAPK signaling coordinately regulates activity of Rac1 and RhoA for tumor cell motility. Cancer Cell 4: 67-79.
40. Ng AY, Waring P, Ristevski S, Wang C, Wilson T, et al. (2002) Inactivation of the transcription factor Elf3 in mice results in dysmorphogenesis and altered differentiation of intestinal epithelium. Gastroenterology 122: 1455-1466.
41. Camarero N, Mascaro C, Mayordomo C, Vilardell F, Haro D, et al. (2006) Ketogenic HMGCS2 Is a c-Myc target gene expressed in differentiated cells of human colonic epithelium and down-regulated in colon cancer. Mol Cancer Res 4: 645-653.
42. Brabletz T, Jung A, Spaderna S, Hlubek F, Kirchner T, (2005) Opinion: migrating cancer stem cells- an integrated concept of malignant tumour progression. Nat Rev Cancer 5: 744-749.
43. Le NH, Franken P, Fodde R, (2008) Tumour-stroma interactions in colorectal cancer: converging on beta-catenin activation and cancer stemness. Br J Cancer 98: 1886-1893.
44. Polyak K, Weinberg RA, (2009) Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 9: 265-273.
45. Conacci-Sorrell M, Simcha I, Ben-Yedidia T, Blechman J, Savagner P, et al. (2003) Autoregulation of E-cadherin expression by cadherin-cadherin interactions: the roles of beta-catenin signaling, Slug, and MAPK. J Cell Biol pp. 847-857.
46. Fritzmann J, Morkel M, Besser D, Budczies J, Kosel F, et al. (2009) A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential. Gastroenterology 137: 165-175.
47. Korinek V, Barker N, Moerer P, van Donselaar E, Huls G, et al. (1998) Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nat Genet 19: 379-383.
48. van de Wetering M, Sancho E, Verweij C, de Lau W, Oving I, et al. (2002) The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 111: 241-250.
49. Varnat F, Duquet A, Malerba M, Zbinden M, Mas C, et al. (2009) Human colon cancer epithelial cells harbour active HEDGEHOG-GLI signalling that is essential for tumour growth, recurrence, metastasis and stem cell survival and expansion. EMBO Mol Med 1: 338-351.
50. Gulino A, Ferretti E, De Smaele E, (2009) Hedgehog signalling in colon cancer and stem cells. EMBO Mol Med 1: 300-302.
51. Fu Y, Kim I, Lian P, Li A, Zhou L, et al. (2010) Loss of Bicc1 impairs tubulomorphogenesis of cultured IMCD cells by disrupting E-cadherin-based cell-cell adhesion. Eur J Cell Biol 89: 428-436.
52. Mizuhara E, Nakatani T, Minaki Y, Sakamoto Y, Ono Y, et al. (2005) MAGI1 recruits Dll1 to cadherin-based adherens junctions and stabilizes it on the cell surface. J Biol Chem 280: 26499-26507.
53. Dignass AU, Tsunekawa S, Podolsky DK, (1994) Fibroblast growth factors modulate intestinal epithelial cell growth and migration. Gastroenterology 106: 1254-1262.
54. Sonvilla G, Allerstorfer S, Heinzle C, Stattner S, Karner J, et al. (2010) Fibroblast growth factor receptor 3-IIIc mediates colorectal cancer growth and migration. Br J Cancer 102: 1145-1156.
55. Gayet J, Zhou XP, Duval A, Rolland S, Hoang JM, et al. (2001) Extensive characterization of genetic alterations in a series of human colorectal cancer cell lines. Oncogene 20: 5025-5032.
56. Vasudevan KM, Barbie DA, Davies MA, Rabinovsky R, McNear CJ, et al. (2009) AKT-Independent Signaling Downstream of Oncogenic PIK3CA Mutations in Human Cancer. Cancer Cell 16: 21-32.